EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY-NC-ND 4.0

Early increase in eosinophil count may predict long‐term hypereosinophilia during dupilumab treatment: a 2‐year observational study

Andrea Rampi iD, Umberto Tanzini, Alessandro Vinciguerra, Giulia Danè, Luca Moroni, Mona-Rita Yacoub, Matteo Trimarchi iD

International Forum of Allergy & Rhinology · 2023-12 · 13 (12) · 2244-2247

DOI: 10.1002/alr.23212 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Forum of Allergy & Rhinology, 2023-07. Verfasst von Andrea Rampi und 6 weiteren Autor:innen. Beteiligte Einrichtung: Otorhinolaryngology Unit, Division of Head and Neck department, IRCCS San Raffaele Scientific Institute, Milan, Italy. Hauptthemen laut MEDLINE: Sinusitis, Rhinitis, Eosinophilia, Nasal Polyps. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Key points In a limited subset of patients, dupilumab‐induced hypereosinophilia is persistent. Two‐month follow‐up eosinophil count may predict long‐lasting hypereosinophilia.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SinusitisRhinitisEosinophiliaNasal PolypsHumansEosinophilsChronic DiseaseAntibodies, Monoclonal, Humanized

Stichwörter der Autor:innen

chronic rhinosinusitiseosinophilic rhinitis and nasal polyposisparanasal sinus diseasestherapeutics

Substanzen

dupilumabAntibodies, Monoclonal, Humanized

Autor:innen und Institutionen

  • Otorhinolaryngology Unit, Division of Head and Neck department, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • School of Medicine, Vita-Salute San Raffaele University, Milan, Italy.
  • Otorhinolaryngology and Skull Base Center, AP-HP, Hospital Lariboisière, Paris, France.
  • Unit of Immunology, Rheumatology, Allergy and Rare Diseases, IRCCS San Raffaele Scientific Institute, Milan, Italy.
  • Department of Otolaryngology-Head and Neck Surgery, Ente Ospedaliero Cantonale, Ospedale Regionale di Lugano - Università della Svizzera Italiana, Lugano, Switzerland.

ORCID-Profile: Andrea Rampi, Matteo Trimarchi

Zitieren

APA

Rampi, A., Tanzini, U., Vinciguerra, A., Danè, G., Moroni, L., Yacoub, M. R., & Trimarchi, M. (2023). Early increase in eosinophil count may predict long‐term hypereosinophilia during dupilumab treatment: a 2‐year observational study. International Forum of Allergy & Rhinology, 13(12), 2244-2247. https://doi.org/10.1002/alr.23212

Vancouver

Rampi A, Tanzini U, Vinciguerra A, Danè G, Moroni L, Yacoub MR, et al. Early increase in eosinophil count may predict long‐term hypereosinophilia during dupilumab treatment: a 2‐year observational study. International Forum of Allergy & Rhinology. 2023;13(12):2244-2247. doi:10.1002/alr.23212

BibTeX
@article{Rampi2023,
  author = {Rampi, Andrea and Tanzini, Umberto and Vinciguerra, Alessandro and Danè, Giulia and Moroni, Luca and Yacoub, Mona-Rita and Trimarchi, Matteo},
  title = {Early increase in eosinophil count may predict long‐term hypereosinophilia during dupilumab treatment: a 2‐year observational study},
  journal = {International Forum of Allergy & Rhinology},
  year = {2023},
  volume = {13},
  number = {12},
  pages = {2244--2247},
  doi = {10.1002/alr.23212}
}
Kostenlos starten →